JCL Roundtable: diagnosis of severe familial hypercholesterolemia

W Virgil Brown1, Daniel J Rader, John Kane

  • 1Emory University School of Medicine, 3208 Habersham Road NW, Atlanta, GA 30305, USA.

Insights

Diagnosing familial hypercholesterolemia is typically straightforward, based on high cholesterol levels and parental history. Identifying the specific genetic causes behind this condition, however, presents greater complexity.

Area of Science:

  • Genetics
  • Biochemistry
  • Cardiovascular Medicine

Background:

  • Familial hypercholesterolemia (FH) is a common genetic disorder.
  • Clinical diagnosis relies on elevated low-density lipoprotein cholesterol (LDL-C) and family history.
  • Tendon xanthomata are characteristic but not always present.

Purpose of the Study:

  • To explore the complexities of identifying genetic variants in patients with phenotypic familial hypercholesterolemia.
  • To discuss the challenges in correlating genetic findings with the clinical presentation of FH.

Main Methods:

  • This content is based on a roundtable discussion with experts in FH genetics.
  • Expert knowledge and experience in identifying genetic abnormalities associated with FH were shared.

Main Results:

  • The clinical diagnosis of FH is often clear.
  • Determining the underlying genetic variants is a more intricate process.
  • Expert insights were provided on the genetic landscape of FH.

Conclusions:

  • While clinically diagnosed FH is usually evident, pinpointing specific genetic causes requires advanced genetic analysis.
  • Collaboration with genetic experts is crucial for a comprehensive understanding of FH etiology.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K